Centessa Pharmaceuticals (CNTA) has released an update to notify the public and investors about a regulation fd disclosure.
Centessa Pharmaceuticals plc regularly updates the investment community with slide presentations at various conferences, sharing summaries and developments in its business. The latest clinical data presentation is now accessible on the “Investors” section of their website, following its showcase at the European Association for Haemophilia and Allied Disorders Congress. While this information is made available to the public, the company does not commit to revising or updating the provided materials.
For further insights into CNTA stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
